# Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

> **NCT00091975** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 78 (—)

## Conditions studied

- Kidney Disease

## Interventions

- **DRUG:** Zemplar Capsule

## Key facts

- **NCT ID:** NCT00091975
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 78 (—)
- **Last updated:** 2011-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091975, "Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00091975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*